UAE Health Ministry helps low-income expats with affordable medicines

UAE Health Ministry helps low-income expats with affordable medicines

The initiative aims to provide affordable medicines to uninsured and low-income expat patients or those whose insurance is not covering the cost of treatment of the following diseases; pulmonary arterial hypertension, multiple myeloma, active ulcerative colitis, and psoriatic arthritis. The MoU was first signed in December 2018, and about 712 eligible patients benefited from it. In April 2019, an extension of the programme was signed to provide new medication to patients with the aforementioned conditions. The agreement is part of the ministry's, Janssen's, and Axios's commitment to improving access to innovative drugs, especially for low-income expat patients who can't afford the costs of their treatment. The MoU was signed by Dr Amin Hussein Al Amiri, Assistant Undersecretary for the Health Regulation Sector, MoHAP, Jimmy Faris, Managing Director, the Janssen Pharmaceutical Companies of Johnson & Johnson, and Anas Al-Safarini, Senior Director, MENA, Axios International. The agreement was signed at the US pavilion, Expo 2020 Dubai, in the presence of the US Consul General Meghan Gregonis and the accompanying delegation along with a number of officials from Janssen and Axios Dr Amin Hussein Al Amiri said: "MoHAP is committed to providing the best medicines for all low-income expat patients in the country.